Abstract
Aim.Compare the effects of bisoprolol, nebivolol and sotalol on the functional state of patients with ventricular arrhythmias (VA).
 Material and methods.120 patients with VA against the background of essential hypertension or its combination with coronary heart disease took part in the research, they were randomized into three groups for treatment with bisoprolol, nebivolol and sotalol. As part of combination therapy, patients were administered lisinopril, and if indicated, acetylsalicylic acid, atorvastatin. Initially and after 24 weeks of therapy the following was done: echocardiography, treadmill test, six-minute walk test, subjective assessment of quality of life, all-day monitoring of blood pressure and electrocardiogram.
 Results.With comparable hypotensive and antiarrhythmic effects, therapy with nebivolol increased exercise tolerance to a greater extent, in comparison with bisoprolol and sotalol. Nebivolol and sotalol improved the quality of life, in comparison with bisoprolol.
 Conclusion.In patients with VA against the background of essential hypertension or its combination with coronary heart disease as part of combination therapy the use of nebivolol may be preferable to bisoprolol or sotalol due to a more pronounced positive effect on the functional state.
Highlights
they were randomized into three groups for treatment
1. В составе комбинированной терапии применение бисопролола, небиволола или соталола у пациентов с желудочковых нарушений ритма сердца (ЖНРС) на фоне гипертоническая болезнь (ГБ) II–III стадии или ее сочетания с ишемическая болезнь сердца (ИБС) вызывало сопоставимые целевые антиаритмические и гипотензивные эффекты, улучшение диастолической функции левого желудочка (ЛЖ)
Summary
Исходная характеристика пациентов с ЖНРс на фоне ГБ ii–iii стадии или ее сочетания с иБс и дозы основных фармакопрепаратов (M±SD) Цель исследования – сравнить влияние бисопролола, небиволола и соталола на функциональное состояние пациентов с желудочковыми нарушениями ритма сердца.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
